Goldman Sachs’s Rockwell Medical RMTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-217
Closed -$179K 7210
2016
Q1
$179K Buy
+217
New +$170K ﹤0.01% 5704
2015
Q3
Sell
-545
Closed -$967K 7462
2015
Q2
$967K Buy
+545
New +$693K ﹤0.01% 4567
2014
Q3
Sell
-1,364
Closed -$1.8M 7231
2014
Q2
$1.8M Buy
+1,364
New +$1.64M ﹤0.01% 4092
2014
Q1
Sell
-907
Closed -$1.04M 6895
2013
Q4
$1.04M Hold
907
﹤0.01% 4713
2013
Q3
$1.14M Buy
+907
New +$616K ﹤0.01% 4480

Other funds holding RMTI

Goldman Sachs's RMTI Position: Q2 2025 in Review

Goldman Sachs sold out of Rockwell Medical (RMTI) in Q2 2025, closing a stake of 4,012 shares — an estimated $45.3K sold.

Goldman Sachs first reported a position in RMTI in Q3 2013 and held it in 31 quarters. The position peaked at $3.24M in Q2 2014. 41 funds tracked by Wall St. Rank hold RMTI as of Q2 2025.

  • Goldman Sachs reported no remaining Rockwell Medical position as of Q2 2025 after selling out during the quarter.
  • Goldman Sachs sold 4,012 Rockwell Medical shares in Q2 2025, an estimated $45.3K.
  • Goldman Sachs first reported a position in Rockwell Medical in Q3 2013 and held it in 31 quarters.
  • Goldman Sachs's Rockwell Medical position peaked at $3.24M in Q2 2014.
  • 41 funds tracked by Wall St. Rank held Rockwell Medical as of Q2 2025.

Based on Goldman Sachs's 13F filing for Q2 2025, filed 14 Aug 2025.